Core Points - Yang Mingyuan has resigned from his positions as a director, board secretary, and financial officer of Jiangsu Yahon Pharmaceutical Technology Co., Ltd. due to personal reasons [1][2] - The resignation does not affect the minimum number of board members required by law and will not disrupt the normal operations of the board [1] - The company will promptly appoint a new board secretary and financial officer, with interim responsibilities assigned to the chairman and deputy general manager [1][2] Summary by Sections Resignation Details - Yang Mingyuan submitted his resignation report and will no longer hold any positions within the company after his departure [1] - He directly holds 59,800 shares, approximately 0.01% of the total share capital, and indirectly holds about 682,900 shares through a partnership, representing around 0.12% of the total share capital [2] Impact on the Company - The resignation is in compliance with relevant laws and regulations, ensuring that the board remains functional [1] - Yang Mingyuan has confirmed that there are no unfulfilled public commitments or disagreements with the company [1] Interim Arrangements - PAN KE will temporarily assume the role of board secretary, while ZHUANG CHENGFENG JOHN will take on the responsibilities of the financial officer until new appointments are made [1][3]
江苏亚虹医药科技股份有限公司关于公司董事兼高级管理人员离任的公告